This issue of Surgical Pathology Clinics, guest edited by Mina L. Xu, will focus on Hematopathology. Topics include, but are not limited to, EBV associated Lymphoproliferative Disorders; Castleman lymphadenopathy; Early events in lymphoid neoplasms; Changes in cutaneous T-cell lymphoma diagnostic and prognostic considerations; Bone Pathology for Hematopathologists; Acute Leukemias of Ambiguous Lineage; Optimal minimal residual disease testing for AML; Defining boundaries between MDS, MPN and MDS/MPN; Updates in pediatric lymphomas; New entities in gastrointestinal lymphoproliferative disorders; Prognostication in Diffuse Large B-cell Lymphomas; Histiocytic Neoplasms commonly encountered by hematopathologists; and Challenges in the diagnosis of grey zone lymphomas.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms - p. 651 9. Optimal Measurable Residual Disease Testing for Acute Myeloid Leukemia - p. 671 10. Acute Leukemias of Ambiguous Lineage: Clarification on Lineage Specificity - p. 687 11. Prognostic and Predictive Biomarkers in Diffuse Large B-cell Lymphoma - p. 699 12. Challenges in the Diagnosis of Gray Zone Lymphomas - p. 709 13. Early Events in Lymphoid Neoplasms and Indolent Follicular Lymphomas - p. 719 14. New/Revised Entities in Gastrointestinal Lymphoproliferative Disorders - p. 733 15. EBV–Associated Lymphoproliferative Disorders: Update in Classification - p. 745 16. Human Immunodeficiency Virus-Associated Lymphoproliferative Disorders - p. 771 17. Recent Advances in Cutaneous T-cell Lymphoma: Diagnostic and Prognostic Considerations - p. 783 18. Histiocytic and Dendritic Cell Neoplasms - p. 805 19. Bone Pathology for Hematopathologists - p. 831 20. Castleman Disease - p. 849
This issue of Surgical Pathology Clinics, guest edited by Mina L. Xu, will focus on Hematopathology. Topics include, but are not limited to, EBV associated Lymphoproliferative Disorders; Castleman lymphadenopathy; Early events in lymphoid neoplasms; Changes in cutaneous T-cell lymphoma diagnostic and prognostic considerations; Bone Pathology for Hematopathologists; Acute Leukemias of Ambiguous Lineage; Optimal minimal residual disease testing for AML; Defining boundaries between MDS, MPN and MDS/MPN; Updates in pediatric lymphomas; New entities in gastrointestinal lymphoproliferative disorders; Prognostication in Diffuse Large B-cell Lymphomas; Histiocytic Neoplasms commonly encountered by hematopathologists; and Challenges in the diagnosis of grey zone lymphomas.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms - p. 651 9. Optimal Measurable Residual Disease Testing for Acute Myeloid Leukemia - p. 671 10. Acute Leukemias of Ambiguous Lineage: Clarification on Lineage Specificity - p. 687 11. Prognostic and Predictive Biomarkers in Diffuse Large B-cell Lymphoma - p. 699 12. Challenges in the Diagnosis of Gray Zone Lymphomas - p. 709 13. Early Events in Lymphoid Neoplasms and Indolent Follicular Lymphomas - p. 719 14. New/Revised Entities in Gastrointestinal Lymphoproliferative Disorders - p. 733 15. EBV–Associated Lymphoproliferative Disorders: Update in Classification - p. 745 16. Human Immunodeficiency Virus-Associated Lymphoproliferative Disorders - p. 771 17. Recent Advances in Cutaneous T-cell Lymphoma: Diagnostic and Prognostic Considerations - p. 783 18. Histiocytic and Dendritic Cell Neoplasms - p. 805 19. Bone Pathology for Hematopathologists - p. 831 20. Castleman Disease - p. 849
